Unexpected Healing of Urorectal Fistula Following Radical Prostatectomy After Leuprolide Atrigel Injection
The essential treatment of choice for organ confined prostate cancer (PCa) is radical prostatectomy (RP). Complications can occur after RP, even extremely ones. However, surgical intervention is needed to fix most of the complications, some of them rarely may be self-healing. We here presented a RP case which rectal injury occurred during RP. However, rectal injury was operated properly, urorectal fistula occurred in follow-up. After the first administration of leuprolide atrigel 22.5mg was given, colostomy was performed. At the end of 2. administration of leuprolide atrigel 22.5 injection, there was not urorectal fistula. After removing urethral catheter, the patient was also continent.
Sağlık Bakanlığı. Türkiye Kanser İstatistikleri 2015. Available at: https://hsgm.saglik.gov.tr/depo/birimler/kanser-db/istatistik/Turkiye_Kanser_Istatistikleri_2015.pdf. Accessed Mar 12, 2019.
2. Gözen AS, Akin Y, Ates M, Hruza M, Rassweiler J. Impact of laparoscopic radical prostatectomy on clinical T3 prostate cancer: experience of a single centre with long-term follow-up. BJU Int 2015;116:102–8.
3. Pieczonka CM, Twardowski P, Renzulli J 2nd, Hafron J, BoldtHoule DM, Atkinson S, et al. Effectiveness of Subcutaneously Administered Leuprolide Acetate to Achieve Low NadirTestosterone in Prostate Cancer Patients. Rev Urol 2018;20:63–8.
4. Gözen AS, Akin Y, Özden E, Ates M, Hruza M, Rassweiler J. Impact of body mass index on outcomes of laparoscopic radical prostatectomy with long-term follow-up. Scand J Urol 2015;49:70–6.
5. Jhaveri H, Combs K, Jhaveri F. Direct Extension of Prostatic Adenocarcinoma Protruding Through the Urethral Meatus. Urol Case Rep 2017;13:13–5.
6. Venkatesan K, Zacharakis E, Andrich DE, Mundy AR. Conservative management of urorectal fistulae. Urology 2013;81:1352– 6.
7. Schraudenbach P, Bermejo CE. Management of the complications of radical prostatectomy. Curr Urol Rep 2007;8:197–202.
8. Michaelson MD, Cotter SE, Gargollo PC, Zietman AL, Dahl DM, Smith MR. Management of complications of prostate cancer treatment. CA Cancer J Clin 2008;58:196–213. [CrossRef]
9. Zaid UB, McAninch JW, Glass AS, Cinman NM, Breyer BN. Presentation, management, and outcomes of complications following prostate cancer therapy. Transl Androl Urol 2014;3:150–5.